S. Ken

Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost

S. Ken, L. Vieillevigne, X. Franceries et al. · Radiation Oncology · 2013 · 231 citations · Full text

Medicine, Oncology, Radiation Oncology +17

αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I–II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma

Anne Ducassou, Emmanuelle Uro‐Coste, Pierre Verrelle et al. · European Journal of Cancer · 2013 · 55 citations

Medicine, Oncology, Pharmacology +17

Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging

Anne Laprie, S. Ken, Thomas Filleron et al. · BMC Cancer · 2019 · 53 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Evaluation of the Lactate-to-N-Acetyl-aspartate Ratio Defined With Magnetic Resonance Spectroscopic Imaging Before Radiation Therapy as a New Predictive Marker of the Site of Relapse in Patients With Glioblastoma Multiforme

A. Deviers, S. Ken, Thomas Filleron et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 49 citations

Medicine, Oncology, Radiology +17

Expanding the medical physicist curricular and professional programme to include Artificial Intelligence

Federica Zanca, Irene Hernández‐Girón, Michele Avanzo et al. · Physica Medica · 2021 · 48 citations · Full text

Natural Sciences, Medical Education, Physics +15